Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 127 participants.
Also called NCT06946732
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 127 participants
- Sponsor
- Registry
-
NCT06946732
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06946732. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-01 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism
- Condition
- Pulmonary Embolism (PE)
- Intervention (Device)
- Acostream aspiration
- Lead sponsor
- RenJi Hospital
- Collaborator
- Xiamen Cardiovascular Hospital, Xiamen University
- Collaborator
- Nantong University Affiliated Hospital
- Collaborator
- Chengdu University of Traditional Chinese Medicine
- Collaborator
- Shanghai No.1 Hospital
- Collaborator
- First Affiliated Hospital of Fujian Medical University
- Collaborator
- Jinhua Central Hospital
Record details
- Record id
cardio:ct-nct06946732- Content hash
2559156c66c6a71eda000a7c790249a689b89f8d15413a150f1bfdbcd3a1e445